Back to search
FDAFDA · Food and drugs·Recall number D-1159-2017

Fluorescein Sodium, 5mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

Published September 20, 2017 · Recall initiated: August 15, 2017

Summary

FDA records drug Class II recall D-1159-2017, published September 20, 2017 and initiated August 15, 2017. Recalling firm: Bella Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 644 vials; Lot: Lot #: BPFS41717, Exp. 4/1/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bella Pharmaceuticals, Inc.
Distributor
Nationwide within USA
Lot
Lot #: BPFS41717, Exp. 4/1/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluorescein Sodium, 5mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA. recalled?

Yes. FDA published recall D-1159-2017 on September 20, 2017. Reported hazard: Lack of Assurance of Sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone